Sun Pharmaceutical Industries
₹1,801.00Change from previous close: −0.86%Absolute change: −₹15.60
At a glance
- Revenue growth
- +11.19%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +5.04%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 19.6%
- FY to Mar 2025: 20.8%
Financial data
Amounts in millions of INR; per-share values in INR; shares in millions.
| Item | FY to Mar 2026 | FY to Mar 2025 | FY to Mar 2024 | FY to Mar 2023 | FY to Mar 2022 | FY to Mar 2021 | FY to Mar 2020 | FY to Mar 2019 | FY to Mar 2018 | FY to Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,087,852 | 921,006 | 854,997 | 807,436 | 698,078 | 676,667 | 682,525 | 646,938 | 645,164 | 614,102 |
| Current assets | 638,912 | 526,245 | 434,750 | 398,833 | 348,646 | 304,421 | 316,542 | 310,692 | 316,359 | 329,537 |
| Cash and equivalents | 97,705 | 102,688 | 92,857 | 46,237 | 45,083 | 62,730 | 56,766 | 70,623 | 79,254 | 86,628 |
| Short-term investments | 44,330 | 50,966 | 53,712 | 60,041 | 44,695 | 32,592 | 48,595 | 35,583 | 60,517 | 66,883 |
| Receivables | 159,288 | 136,007 | 119,440 | 119,117 | 110,243 | 98,905 | 105,106 | 100,630 | 84,164 | 84,976 |
| Inventory | 120,585 | 107,593 | 102,949 | 109,683 | 92,392 | 93,618 | 82,692 | 82,624 | 68,807 | 77,351 |
| Net property, plant and equipment | 124,948 | 112,703 | 113,001 | 113,537 | 111,689 | 111,715 | 112,263 | 109,382 | 105,935 | 100,601 |
| Goodwill | 98,331 | 89,394 | 85,690 | 83,580 | 65,913 | 62,876 | 64,815 | 59,558 | 56,067 | 55,362 |
| Other intangible assets | 135,462 | 90,205 | 87,330 | 93,268 | 61,918 | 56,607 | 63,595 | 63,537 | 51,176 | 48,803 |
| Long-term investments | 37,891 | 46,977 | 64,412 | 54,517 | 49,592 | 64,824 | 52,458 | 39,518 | 30,523 | 14,198 |
| Current liabilities | 226,220 | 181,942 | 169,844 | 199,070 | 172,085 | 161,456 | 157,064 | 173,396 | 198,643 | 178,870 |
| Accounts payable | 73,338 | 61,843 | 56,533 | 56,815 | 44,898 | 39,737 | 35,836 | 41,479 | 47,662 | 43,954 |
| Long-term debt | 313 | 25.2 | 13.3 | 0.0 | 2,299 | 6,547 | 17,776 | 14,229 | 16,688 | 13,698 |
| Total debt | 5,770 | 4,951 | 4,293 | 9,276 | 8,218 | 14,237 | 27,655 | 21,436 | 24,056 | 31,769 |
| Total liabilities | 249,055 | 196,146 | 183,737 | 214,281 | 187,417 | 181,869 | 191,278 | 199,712 | 223,181 | 209,797 |
| Total equity (incl. minority) | 838,797 | 724,860 | 671,259 | 593,155 | 510,661 | 494,798 | 491,247 | 447,226 | 421,983 | 404,305 |
| Retained earnings | 694,677 | 614,525 | 537,452 | 472,009 | 412,363 | 401,887 | 389,052 | 369,130 | 355,359 | 342,036 |
| Minority interest | 3,097 | 2,679 | 34,592 | 33,201 | 30,549 | 30,171 | 38,602 | 33,135 | 38,842 | 37,909 |
